Compared with the treat-none or treat-all scheme, patients with BC could obtain a significant net benefit from the Rad-Score and nomogram models, which is revealed in decision curve analysis, indicating that both models are valuable in predicting the Ki-67 status. Here, MKI67 is linked to breast cancer.